A carregar...

Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)

EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) is a preferred regimen for HIV-non-Hodgkin lymphomas (HIV-NHLs), which are frequently Epstein-Barr virus (EBV) positive or human herpesvirus type-8 (HHV-8) positive. The histone deacetylase (HDAC) inhibitor vorinostat disr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Ramos, Juan C., Sparano, Joseph A., Chadburn, Amy, Reid, Erin G., Ambinder, Richard F., Siegel, Eric R., Moore, Page C., Rubinstein, Paul G., Durand, Christine M., Cesarman, Ethel, Aboulafia, David, Baiocchi, Robert, Ratner, Lee, Kaplan, Lawrence, Capoferri, Adam A., Lee, Jeannette Y., Mitsuyasu, Ronald, Noy, Ariela
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7483436/
https://ncbi.nlm.nih.gov/pubmed/32430507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019003959
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!